Clik here to view.
BeiGene Launches Proposed Public Offering by Selling Shareholders
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
LG Chem Life Sciences and TransThera Biosciences Announce FDA Clearance of...
SEOUL, Korea & NANJING, China LG Chem Life Sciences (“LG Chem”), a division of LG Chem, and TransThera Biosciences Co. Ltd. (“TransThera”), a clinical-stage biotechnology company based in...
View ArticleClik here to view.
研究比较机械通气患者液体反应性的两种无创指标，发现MasimoPVi®有效且具有优势
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天发布《艾因夏姆斯麻醉学杂志》发表的一项研究结果，该研究中，埃及开罗艾因夏姆斯大学(Ain-Shams University)的Diaaeldin Aboelnile博士及其同事比较两种评估机械通气患者液体反应性的无创方法dIVC和Masimo...
View ArticleClik here to view.
人工呼吸器患者におけ輸液反応の非侵襲的指標2種を比較した研究からMasimo PVi®の効果と利点が判明
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ：MASI）は本日、アインシャムス大学（エジプト、カイロ）のDr. Diaaeldin Aboelnileと同僚らがAin-Shams Journal of Anesthesiologyに発表した研究の結果を発表しました。この研究では、人工呼吸器患者におけ輸液反応を評価するための2つの非侵襲的方法、すなわちdIVCとMasimo...
View ArticleClik here to view.
BeiGene Announces Pricing of Public Offering by Selling Shareholders
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
PierianDxが世界市場でのがんゲノムレポート作成を支えるべくイルミナとの提携拡大を発表
セントルイス （ビジネスワイヤ） — 臨床ゲノムインフォマティクスの有力企業であるPierianDxは本日、イルミナとの提携を拡大し、PierianDxのゲノムレポートソリューションをAmpliSeq™ for Illumina® Focus Panel、AmpliSeq™ for Illumina® Myeloid Panel、TruSight™ Hereditary Cancer...
View ArticleClik here to view.
PierianDx宣布与Illumina扩大伙伴关系，在全球市场支持癌症基因组报告
圣路易斯 (美国商业资讯)–领先的临床基因组信息学公司PierianDx今天宣布与Illumina扩大伙伴关系，以使PierianDx基因组报告解决方案可用于AmpliSeq™ for Illumina® Focus Panel、AmpliSeq™ for Illumina® Myeloid Panel、TruSight™ Hereditary Cancer...
View ArticleClik here to view.
Independent Discovery Validates Noxopharm’s DARRT Cancer Therapy
SYDNEY Australian clinical-stage drug development company, Noxopharm (ASX: NOX), is pleased to announce that a discovery by Weill Cornell Medical College in New York, recently published in the...
View ArticleClik here to view.
Clik here to view.
Neuboron Medtech, a BNCT Total Solution Provider, Enters Joint-Venture...
NANJING, China Neuboron Therapy System (NTS), a wholly owned subsidiary of Neuboron Medtech, announced today it has approved an approximate USD 10 million of minority equity investment from TAE Life...
View ArticleClik here to view.
Shape Therapeutics推出AAVid™衣壳发现平台和新型组织特异性AAV变异识别，解决基因治疗根本性的投药挑战
西雅图 (美国商业资讯)–拥有行业领先的RNA靶向技术平台的下一代基因治疗公司Shape Therapeutics, Inc. (ShapeTX)今天宣布推出AAVidTM衣壳发现平台，并发布来自一次非人类灵长类选择活动的首个AAV5变异文库的结果。...
View ArticleClik here to view.
Sherlock Biosciences Strengthens Intellectual Property Portfolio in...
CAMBRIDGE, Mass. Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced exclusive license agreements with...
View ArticleClik here to view.
BeiGene Announces Data on BRUKINSA® (Zanubrutinib) from Phase 2 Trial in...
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
シェイプ・セラピューティクスがAAVid™カプシド発見プラットフォームを公開し、新規の組織特異的AAVバリアントを発見して、遺伝子治療におけるデリバリーの...
シアトル （ビジネスワイヤ） — 業界有数のRNA標的化技術プラットフォームを持つ次世代遺伝子治療技術企業のシェイプ・セラピューティクス（ShapeTX）は本日、AAVid™カプシド発見プラットフォームの公開と、非ヒト霊長類での選択キャンペーンで初のAAV5バリアントライブラリーにおける結果を発表しました。...
View ArticleClik here to view.
Veristat Named Top Patient Recruitment Company 2020 by Pharma Tech Outlook
SOUTHBOROUGH, Mass. Veristat, a global clinical research organization, was named among the Top Patient Recruitment Companies of 2020 by Pharma Tech Outlook. With over 26 years’ experience partnering...
View ArticleClik here to view.
Takeda Presents Real-World Evidence at ASH 2020, Demonstrating Its...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”), today presented five hematology poster presentations and four abstracts at the 62nd...
View ArticleClik here to view.
BeiGene Presents Clinical Data on BRUKINSA® (Zanubrutinib) in B-Cell...
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
Rhizen Pharmaceuticals SA宣布在美国血液学会(ASH) 2020年会上呈报Tenalisib...
瑞士拉绍德封 (美国商业资讯)–专攻肿瘤学的临床阶段生物制药公司Rhizen Pharmaceuticals今天宣布，将在2020年12月5日至8日召开的美国血液病学会(ASH)第62届视频年会和展会上呈报Tenalisib联合Romidepsin治疗复发/难治T细胞淋巴瘤患者I/II期研究的中期结果。...
View ArticleClik here to view.
Kubota Vision Announces Submission of Novel VAP-1 Inhibitors to the NCI...
SEATTLE Kubota Vision Inc. (“Kubota Vision”), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today...
View ArticleClik here to view.
BeiGene Announces the Approval in China of BLINCYTO® (Blinatumomab) for...
BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View Article